Skip to main content

News

All the latest news and information on the main advances in research, institutional milestones, teaching and management. Find out what happens at the Vall d'Hebron Research Institute!

Vall d'Hebron has coordinated this initiative that has carried out numerous training and community awareness activities aimed at empowering young people in sexual and reproductive health issues.

Hybrids VITA, developed together with Medical Simulator, reproduces different clinical scenarios for training on how to prevent, diagnose and treat possible complications of ECMO, which is a very complex technique.

The conclusions from the 1st International Congress on Health Communication will provide the basis for a Guide to Health Communication, which will be share with the European University Hospital Alliance (EUHA).

Practical workshops and the Meet the Expert session, so that attendees could interact directly with some of the speakers, complete the round tables.

More than 400 professionals from the fields of health, communication, and political institutions exchange reflections and experiences. Experts warn about the impact of misinformation and the need for transparent and effective communication

A study by the Infectious Diseases group at VHIR has found that some people with HIV can uniquely control the virus thanks to a special type of cell in their immune system.

The awarded projects will study the immune response to HIV and the VIGex tool as a biomarker for immunotherapy response.

Extracorporeal Cardiopulmonary Resuscitation (ECPR) offers therapeutic options for patients in whom conventional cardiopulmonary resuscitation techniques fail to restore the heartbeat.

Over 24 and 25 October, the congress will look into different issues, including communication for government health policies, the relationship between health institutions and journalists or crisis scenarios.

For three days, the III Stroke Congress of the national RICORS-ICTUS network and a symposium focused on cerebral haemorrhage were held.

The funds will strengthen research lines focused on nervous system tumors.

The European Rare Diseases Research Alliance (ERDERA) kicked off this September, with an estimated budget of 380 million euros and the aim of improving the lives of 30 million rare disease patients in Europe and beyond.

UMBRELLA, a consortium of over 20 public and private partners, kicks off this week with the aim of revolutionising the entire stroke care pathway in Europe by adopting a holistic approach that covers stroke diagnosis, prevention and care.

Welcoming the students of the 1st edition of the Master’s in Clinical Trials Management and Coordination and the 11th edition of the Master’s in Translational Biomedical Research.

On World Cancer Research Day, we highlight research aimed at improving treatments for both pediatric and adult cancers through innovative techniques.

The Vall d’Hebron Institute of Research’s Paediatric Cancer and Hematological Diseases Research Group Achieves Promising Results for Acute Graft-Versus-Host Disease.

This project of personalized and regenerative medicine will carry out the first clinical trial in Spain to treat burns and skin wounds with bioprinted autologous human skin substitutes.

This recognition highlights both his career and the level of respiratory research in Spain.

The Neonatology Service aims to demonstrate that the individual family room for newborns is more beneficial than the shared box room.

The ERS Awards recognize outstanding members for their exceptional contributions in the field of respiratory medicine.

The awarded study is titled “Perceptions and experiences of parents of premature newborns with an umbilical venous catheter who perform skin-to-skin contact,” and the granted scholarship will allow for its dissemination.

The Multidisciplinary Cancer Committee has evaluated a total of 701 patients since its creation.

The study aims to investigate how excess body fat alters the number and function of T lymphocytes, leading to a greater predisposition to infectious diseases.

The head of the Diagnostic Nanotools (DINA) group was part of a Spanish delegation that also participated in activities to establish contracts between national and international centers.